Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
Turpie AGG, Farjat AE, Haas S, Ageno W, Weitz JI, Goldhaber SZ, Goto S, Angchaisuksiri P, Kayani G, Lopes RD, Chiang CE, Gibbs H, Tse E, Verhamme P, Ten Cate H, Muntaner J, Schellong S, Bounameaux H, Prandoni P, Maheshwari U, Kakkar AK; GARFIELD-VTE investigators. Turpie AGG, et al. Among authors: angchaisuksiri p. Thromb Res. 2023 Feb;222:31-39. doi: 10.1016/j.thromres.2022.11.016. Epub 2022 Nov 25. Thromb Res. 2023. PMID: 36565677 Free article.
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Weitz JI, et al. Among authors: angchaisuksiri p. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x. J Thromb Thrombolysis. 2020. PMID: 32583306
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease.
Haas S, Farjat AE, Pieper K, Ageno W, Angchaisuksiri P, Bounameaux H, Goldhaber SZ, Goto S, Mantovani L, Prandoni P, Schellong S, Turpie AGG, Weitz JI, MacCallum P, Cate HT, Panchenko E, Carrier M, Jerjes-Sanchez C, Gibbs H, Jansky P, Kayani G, Kakkar AK; GARFIELD-VTE investigators. Haas S, et al. Among authors: angchaisuksiri p. TH Open. 2022 Nov 3;6(4):e354-e364. doi: 10.1055/s-0042-1757744. eCollection 2022 Oct. TH Open. 2022. PMID: 36452204 Free PMC article.
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH).
Liam CCK, Tiao JY, Yap YY, Lee YL, Sathar J, McRae S, Davis A, Curnow J, Bird R, Choi P, Angchaisuksiri P, Tien SL, Lam JCM, Oh D, Kim JS, Yoon SS, Wong RS, Lauren C, Merriman EG, Enjeti A, Smith M, Baker RI. Liam CCK, et al. Among authors: angchaisuksiri p. Blood Res. 2023 Mar 31;58(1):36-41. doi: 10.5045/br.2023.2022133. Epub 2023 Jan 12. Blood Res. 2023. PMID: 36632683 Free PMC article.
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.
Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V; explorer7 Investigators. Matsushita T, et al. Among authors: angchaisuksiri p. N Engl J Med. 2023 Aug 31;389(9):783-794. doi: 10.1056/NEJMoa2216455. N Engl J Med. 2023. PMID: 37646676 Clinical Trial.
ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary.
Siegal DM, Tseng EK, Schünemann HJ, Angchaisuksiri P, Cuker A, Dane KE, DeSancho MT, Diuguid DL, Griffin DO, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo K, Terrell DR, Akl EA, Al Jabiri RN, Al Jabiri YN, Barbara AM, Bognanni A, Bou Akl I, Boulos M, Brignardello-Petersen R, Chan M, Charide R, Colunga-Lozano LE, Dearness KL, Darzi AJ, Hussein H, Karam SG, Kolb P, Mansour R, Morgano GP, Morsi RZ, Muti Schuenemann GEU, Nadim MK, Noori A, Philip BA, Piggott T, Qiu Y, Benitez YR, Schünemann F, Stevens A, Solo K, Wiercioch W, Mustafa RA, Nieuwlaat R. Siegal DM, et al. Among authors: angchaisuksiri p. Blood Adv. 2024 Oct 22:bloodadvances.2024014219. doi: 10.1182/bloodadvances.2024014219. Online ahead of print. Blood Adv. 2024. PMID: 39437797
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial.
Chowdary P, Angchaisuksiri P, Apte S, Astermark J, Benson G, Chan AKC, Jiménez Yuste V, Matsushita T, Høgh Nielsen AR, Sathar J, Sutton C, Šaulytė Trakymienė S, Tran H, Villarreal Martinez L, Wheeler AP, Windyga J, Young G, Thaung Zaw JJ, Eichler H. Chowdary P, et al. Among authors: angchaisuksiri p. Lancet Haematol. 2024 Nov 6:S2352-3026(24)00307-7. doi: 10.1016/S2352-3026(24)00307-7. Online ahead of print. Lancet Haematol. 2024. PMID: 39521008 Free article.
International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology.
Rezende SM, Neumann I, Angchaisuksiri P, Awodu O, Boban A, Cuker A, Curtin JA, Fijnvandraat K, Gouw SC, Gualtierotti R, Makris M, Nahuelhual P, O'Connell N, Saxena R, Shima M, Wu R, Rosendaal FR. Rezende SM, et al. Among authors: angchaisuksiri p. J Thromb Haemost. 2024 Sep;22(9):2629-2652. doi: 10.1016/j.jtha.2024.05.026. Epub 2024 Jun 20. J Thromb Haemost. 2024. PMID: 39043543 Free article. Review.
132 results